August 19, 2025

10x Genomics, Inc. (TXG) Stock Analysis: Exploring a 12% Potential Upside Amidst Healthcare Innovation

10x Genomics, Inc. (NASDAQ: TXG) is a pivotal player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $1.68..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Evaluating Growth Potential Amidst CNS Drug Innovations

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a key player in the healthcare sector, focuses on developing and commercializing treatments for central nervous system (CNS) disorders. With a..

Novavax, Inc. (NVAX) Stock Analysis: Exploring a 35% Potential Upside Amid Biotech Challenges

Novavax, Inc. (NASDAQ: NVAX) finds itself at a pivotal juncture, presenting an intriguing opportunity for investors who are keen on the biotechnology sector. With a market..

Select Medical Holdings Corp (SEM) Stock Analysis: Exploring a 37.71% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM) is drawing investor attention with its robust presence in the healthcare sector, specifically within the medical care facilities industry. With..

PACS Group, Inc. (PACS) Stock Analysis: A 167% Potential Upside Beckons Investors

PACS Group, Inc. (PACS) is making waves in the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $1.77 billion, this..

MannKind Corporation (MNKD) Investor Outlook: Unpacking a 142.78% Potential Upside with Promising Biotech Innovations

MannKind Corporation (NASDAQ: MNKD), a trailblazing entity in the biotechnology sector, is captivating investor attention with its remarkable potential upside of 142.78%. This is driven by..

Dynavax Technologies Corporation (DVAX) Investor Outlook: Exploring a 116% Potential Upside

Dynavax Technologies Corporation (NASDAQ: DVAX), a key player in the healthcare sector, is garnering attention from investors due to its promising growth prospects and a notable..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 19.5% Upside Potential in the Biotech Sector

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) has been making waves in the biotechnology sector, focusing on developing and commercializing transformative treatments for central nervous system (CNS) disorders..

NewAmsterdam Pharma Company N.V. (NAMS): Investor Outlook on a Promising 58.77% Upside Potential

For investors eyeing the healthcare sector’s vibrant biotechnology industry, NewAmsterdam Pharma Company N.V. (NAMS) presents an intriguing opportunity. Headquartered in Naarden, the Netherlands, this late-stage biopharmaceutical..

Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth Challenges with a 8.48% Potential Upside

For investors eyeing the healthcare sector, Azenta, Inc. (NASDAQ: AZTA) offers a unique opportunity, particularly with its current stock positioning and potential upside. Specializing in medical..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Navigating a 16.8% Revenue Growth in a Competitive Healthcare Sector

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) is emerging as a significant player in the U.S. healthcare sector, particularly in the realm of home care services. Headquartered..

Acadia Healthcare (ACHC) Stock Analysis: Evaluating a 44% Potential Upside Amidst Market Volatility

Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a stalwart in the healthcare sector, particularly in the realm of medical care facilities, presents an intriguing opportunity for investors..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Eyeing a 109% Potential Upside in the Biotech Arena

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is making waves in the biotechnology sector with its promising pipeline of treatments for serious and rare diseases. With a market..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: A 173.81% Upside Potential Captures Investor Interest

Edgewise Therapeutics, Inc. (EWTX), a biopharmaceutical firm headquartered in Boulder, Colorado, is making waves in the biotechnology sector with its promising pipeline targeting muscle disorders. Edgewise..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Unlocking a 189% Potential Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a key player in the biotechnology sector, is gaining traction among investors with its promising focus on rare and ultra-rare genetic..

Celldex Therapeutics, Inc. (CLDX) Investor Outlook: Analyzing the 138.81% Upside Potential

For investors keen on the biotechnology sector, Celldex Therapeutics, Inc. (NASDAQ: CLDX) presents a compelling opportunity. This American biopharmaceutical company, headquartered in Hampton, New Jersey, focuses..

Mesoblast Limited (MESO) Stock Analysis: A 69% Potential Upside Amidst Biotech Challenges

For investors with a keen eye on the biotechnology sector, Mesoblast Limited (NASDAQ: MESO) presents a fascinating opportunity. Headquartered in Melbourne, Australia, Mesoblast specializes in regenerative..

Clover Health Investments (CLOV): A 39.85% Potential Upside Amidst Healthcare Sector Growth

Clover Health Investments, Corp. (NASDAQ: CLOV) is attracting attention in the healthcare plans industry, particularly after a notable 34.10% revenue growth. With a market cap of..

Astrana Health Inc. (ASTH) Stock Analysis: A Promising 46.59% Potential Upside to Entice Investors

Astrana Health Inc. (ASTH), a rapidly growing player in the healthcare sector, is capturing investor attention with its impressive potential upside of 46.59%. Headquartered in Alhambra,..

Alphatec Holdings, Inc. (ATEC)

⚠️ No article content returned.

..
Search

Funds

August 19, 2025

Search

Funds

August 19, 2025

FTSE 100

Funds